FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice

Conclusion: These findings suggest that FGF21 ameliorates diabetic cardiomyopathy in part by activation of the AMPK-PON1 axis.

Source: Clinical Science - May 30, 2017 Category: Biomedical Science Authors: Wu, F., Wang, B., Zhang, S., Shi, L., Wang, Y., Xiong, R., Pan, X., Gong, F., Li, X., Lin, Z. Tags: PublishAheadOfPrint Source Type: research